A rationale to target the SWI/SNF complex for cancer therapy
- 2 June 2014
- journal article
- review article
- Published by Elsevier BV in Trends in Genetics
- Vol. 30 (8), 356-363
- https://doi.org/10.1016/j.tig.2014.05.001
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Mechanisms and Functions of ATP-Dependent Chromatin-Remodeling EnzymesCell, 2013
- Novel mutations target distinct subgroups of medulloblastomaNature, 2012
- The tumour suppressor and chromatin‐remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancerEMBO Molecular Medicine, 2012
- Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain FamilyCell, 2012
- ATP-dependent chromatin remodeling: genetics, genomics and mechanismsCell Research, 2011
- Epigenetic Antagonism between Polycomb and SWI/SNF Complexes during Oncogenic TransformationCancer Cell, 2010
- Understanding the Words of Chromatin RegulationCell, 2009
- Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell linesHuman Mutation, 2008
- An Essential Switch in Subunit Composition of a Chromatin Remodeling Complex during Neural DevelopmentNeuron, 2007
- Nucleosome disruption and enhancement of activator binding by a human SW1/SNF complexNature, 1994